Cargando…

Quantitative flow ratio-guided versus angiography-guided operation for valve disease accompanying coronary heart disease

BACKGROUND: Valve replacement combined with coronary artery bypass graft (CABG) operation (VR + CABG) is usually associated with higher mortality and complication rates. Currently, angiography remains the most commonly used approach to guide CABG. The aim of this study is to investigate whether a qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Wenlong, Wang, Yangyang, Zheng, Xin, Guo, Pengfei, Yang, Sumin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020583/
https://www.ncbi.nlm.nih.gov/pubmed/36937913
http://dx.doi.org/10.3389/fcvm.2023.1076049
_version_ 1784908291254517760
author Yan, Wenlong
Wang, Yangyang
Zheng, Xin
Guo, Pengfei
Yang, Sumin
author_facet Yan, Wenlong
Wang, Yangyang
Zheng, Xin
Guo, Pengfei
Yang, Sumin
author_sort Yan, Wenlong
collection PubMed
description BACKGROUND: Valve replacement combined with coronary artery bypass graft (CABG) operation (VR + CABG) is usually associated with higher mortality and complication rates. Currently, angiography remains the most commonly used approach to guide CABG. The aim of this study is to investigate whether a quantitative flow ratio (QFR)-guided strategy can improve the clinical outcomes of VR + CABG. METHODS: Patients (n = 536) treated by VR + CABG between January 2018 and December 2021 were retrospectively assessed. In 116 patients, all lesions were revascularized entirely based on QFR (the QFR-guided group), whereas in 420 patients, all lesions were revascularized entirely based on angiography (the angiography-guided group). To minimize selection bias between the 2 groups, propensity score matching was performed at a ratio of 1:2. The primary endpoint of the study was the rate of major adverse cardiac and cerebrovascular events (MACCE) at 1-year, which was defined as a composite of cardiac mortality, myocardial infarction (MI), any repeat revascularization, and stroke. RESULTS: No statistically significant differences were observed in the baseline clinical characteristics between the QFR-guided and angiography-guided groups after propensity score matching. The mean age of all patients was 66.2 years [standard deviation (SD) = 8.3], 370 (69%) were men, the mean body-mass index of the population was 24.8 kg/m(2) (SD = 4.5), 129 (24%) had diabetes, and 229 (43%) had angina symptoms. When compared with the angiography-guided group, the QFR-guided group had a significantly shorter operative time (323 ± 60 min vs. 343 ± 71 min, P = 0.010), extra corporal circulation time (137 ± 38 min vs. 155 ± 62 min, P = 0.004), clamp time (73 ± 19 min vs. 81 ± 18 min, P < 0.001), and less intraoperative bleeding volume (640 ± 148 ml vs. 682 ± 166 ml, P = 0.022). Compared with the angiography-guided group, the 1-year MACCE was significantly lower in the QFR-guided group (6.9% vs. 14.7%, P = 0.036, hazard ratio = 0.455, 95% confidence interval: 0.211–0.982). CONCLUSION: Our results raise the hypothesis that among patients who undergo VR + CABG, QFR-guided strategy is associated with optimized surgical procedure and a superior clinical outcome, as evidenced by a lower rate of MACCE at 1-year compared with conventional angiography-guided strategy.
format Online
Article
Text
id pubmed-10020583
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100205832023-03-18 Quantitative flow ratio-guided versus angiography-guided operation for valve disease accompanying coronary heart disease Yan, Wenlong Wang, Yangyang Zheng, Xin Guo, Pengfei Yang, Sumin Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Valve replacement combined with coronary artery bypass graft (CABG) operation (VR + CABG) is usually associated with higher mortality and complication rates. Currently, angiography remains the most commonly used approach to guide CABG. The aim of this study is to investigate whether a quantitative flow ratio (QFR)-guided strategy can improve the clinical outcomes of VR + CABG. METHODS: Patients (n = 536) treated by VR + CABG between January 2018 and December 2021 were retrospectively assessed. In 116 patients, all lesions were revascularized entirely based on QFR (the QFR-guided group), whereas in 420 patients, all lesions were revascularized entirely based on angiography (the angiography-guided group). To minimize selection bias between the 2 groups, propensity score matching was performed at a ratio of 1:2. The primary endpoint of the study was the rate of major adverse cardiac and cerebrovascular events (MACCE) at 1-year, which was defined as a composite of cardiac mortality, myocardial infarction (MI), any repeat revascularization, and stroke. RESULTS: No statistically significant differences were observed in the baseline clinical characteristics between the QFR-guided and angiography-guided groups after propensity score matching. The mean age of all patients was 66.2 years [standard deviation (SD) = 8.3], 370 (69%) were men, the mean body-mass index of the population was 24.8 kg/m(2) (SD = 4.5), 129 (24%) had diabetes, and 229 (43%) had angina symptoms. When compared with the angiography-guided group, the QFR-guided group had a significantly shorter operative time (323 ± 60 min vs. 343 ± 71 min, P = 0.010), extra corporal circulation time (137 ± 38 min vs. 155 ± 62 min, P = 0.004), clamp time (73 ± 19 min vs. 81 ± 18 min, P < 0.001), and less intraoperative bleeding volume (640 ± 148 ml vs. 682 ± 166 ml, P = 0.022). Compared with the angiography-guided group, the 1-year MACCE was significantly lower in the QFR-guided group (6.9% vs. 14.7%, P = 0.036, hazard ratio = 0.455, 95% confidence interval: 0.211–0.982). CONCLUSION: Our results raise the hypothesis that among patients who undergo VR + CABG, QFR-guided strategy is associated with optimized surgical procedure and a superior clinical outcome, as evidenced by a lower rate of MACCE at 1-year compared with conventional angiography-guided strategy. Frontiers Media S.A. 2023-03-03 /pmc/articles/PMC10020583/ /pubmed/36937913 http://dx.doi.org/10.3389/fcvm.2023.1076049 Text en © 2023 Yan, Wang, Zheng, Guo and Yang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Yan, Wenlong
Wang, Yangyang
Zheng, Xin
Guo, Pengfei
Yang, Sumin
Quantitative flow ratio-guided versus angiography-guided operation for valve disease accompanying coronary heart disease
title Quantitative flow ratio-guided versus angiography-guided operation for valve disease accompanying coronary heart disease
title_full Quantitative flow ratio-guided versus angiography-guided operation for valve disease accompanying coronary heart disease
title_fullStr Quantitative flow ratio-guided versus angiography-guided operation for valve disease accompanying coronary heart disease
title_full_unstemmed Quantitative flow ratio-guided versus angiography-guided operation for valve disease accompanying coronary heart disease
title_short Quantitative flow ratio-guided versus angiography-guided operation for valve disease accompanying coronary heart disease
title_sort quantitative flow ratio-guided versus angiography-guided operation for valve disease accompanying coronary heart disease
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020583/
https://www.ncbi.nlm.nih.gov/pubmed/36937913
http://dx.doi.org/10.3389/fcvm.2023.1076049
work_keys_str_mv AT yanwenlong quantitativeflowratioguidedversusangiographyguidedoperationforvalvediseaseaccompanyingcoronaryheartdisease
AT wangyangyang quantitativeflowratioguidedversusangiographyguidedoperationforvalvediseaseaccompanyingcoronaryheartdisease
AT zhengxin quantitativeflowratioguidedversusangiographyguidedoperationforvalvediseaseaccompanyingcoronaryheartdisease
AT guopengfei quantitativeflowratioguidedversusangiographyguidedoperationforvalvediseaseaccompanyingcoronaryheartdisease
AT yangsumin quantitativeflowratioguidedversusangiographyguidedoperationforvalvediseaseaccompanyingcoronaryheartdisease